CIK 1766721
Aisling Capital Management LP
Institutional 13F holdings & portfolio
Holdings
13
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
2
Holdings
13F filings as of Dec 31, 2025 · Showing 1–13 of 13
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| BBIO | BridgeBio Pharma Inc. (BBIO) | 5.1M | $1M+ | SH |
| SNDX | Syndax Pharmaceuticals, Inc. (SNDX) | 1.3M | $1M+ | SH |
| GLUE | Monte Rosa Therapeutics Inc (GLUE) | 1.5M | $1M+ | SH |
| BCAX | Bicara Therapeutics Inc. (BCAX) | 569K | $1M+ | SH |
| CMPS | Compass Pathways Plc (CMPS) | 1.2M | $1M+ | SH |
| BBOT | BridgeBio Oncology Therapeutics (BBOT) | 565K | $1M+ | SH |
| CALC | CalciMedica, Inc. (CALC) | 521K | $1M+ | SH |
| SRRK | Scholar Rock Holding Corporation (SRRK) | 77K | $1M+ | SH |
| BMEA | Biomea Fusion Inc (BMEA) | 2.0M | $1M+ | SH |
| URGN | Urogen Pharma Ltd. (URGN) | 108K | $1M+ | SH |
| ACRS | Aclaris Therapeutics Inc (ACRS) | 434K | $1M+ | SH |
| MRKR | Marker Therapeutics, Inc. (MRKR) | 325K | $100K–$500K | SH |
| OKUR | OnKure Therapeutics, Inc. (OKUR) | 89K | $100K–$500K | SH |